Loading provider…
Loading provider…
Internal Medicine Physician in Hialeah, FL
NPI: 1346279809Primary Practice Location
PALMETTO GENERAL HOSPITAL
2001 W 68th St, Hialeah, FL
Primary Employer
Albert G Logun M D Hubert G Martinez M D P A
pbaco.org
HQ Phone
Get D.O. Jorge's Phone Numberphone_androidMobile
Get D.O. Jorge's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardFL State Medical License

FL State License
1999 - 2026

TX State License
2025 - 2025

American Board of Internal Medicine
Internal Medicine
Dr. Kiran C. Patel College of Osteopathic Medicine
osteopathic.nova.edu
Medical School
Until 1996
Westchester Medical Center
Residency • Internal Medicine
1996 - 1999
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 25 | 135 |
| 2 | G0444Annual depression screening, 15 minutes | 21 | 21 |
| 3 | G0439Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 21 | 21 |
Diagnostic Accuracy of a Bacterial and Viral Biomarker Point-of-Care Test in the Outpatient Setting.
Authors: Jin Han, Teena Hughes, Robert Sambursky, Michael Filbin, Tom Aufderheide
Journal: JAMA Netw Open
Publication Date: 2022-10-03
Authors: Reza Jahan, Ichiro Yuki, Gary Duckwiler, Satoshi Tateshima, Antonio De Salles, Fernando Vinuela
Journal: J Neurosurg
Lead Sponsor: Par Pharmaceutical, Inc.
Collaborators: Novum Pharmaceutical Research Services
Intervention / Treatment: DRUG: Placebo, DRUG: Ciprofloxacin/Dexamethasone, DRUG: Ciprodex (R)
Lead Sponsor: Eli Lilly and Company
Intervention / Treatment: DRUG: Placebo, DRUG: Mirikizumab
Lead Sponsor: Eli Lilly and Company
Intervention / Treatment: DRUG: Placebo IV, DRUG: Vedolizumab IV, DRUG: Placebo SC, DRUG: Mirikizumab SC, DRUG: Mirikizumab IV